keyboard_arrow_up

Muscle Spasm Therapeutic Pipeline H1 2015 Review Research Report

RnRMarketResearch.com adds “Muscle Spasm – Pipeline Review, H1 2015” to its store.

The report “Muscle Spasm – Pipeline Review, H1 2015 ”  provides comprehensive information on the therapeutic development for Muscle Spasm, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Muscle Spasm and special features on late-stage and discontinued projects.

Complete report is available at http://www.rnrmarketresearch.com/muscle-spasm-pipeline-review-h1-2015-market-report.html .

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies discussed in this  Muscle Spasm – Pipeline Review, H1 2015 report include  Eisai Co., Ltd., Omeros Corporation, Revance Therapeutics, Inc., Sanochemia Pharmazeutika AG.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are  (diclofenac sodium + eperisone), (ketoprofen + nifedipine), Drug to Agonize TRPA1 and TRPV1 for Neuromuscular Disorders, NVP-1102, RT-002, tolperisone. Order a purchase copy of this report @  http://www.rnrmarketresearch.com/contacts/purchase?rname=382515 . (This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases cover by this report includes:  Nov 12, 2013: Sanochemia Receives First Patent For Japan; Nov 23, 2012: Sanochemia Receives US Notice Of Allowance For Manufacture Of Tolperisone.

 List of Tables
Number of Products under Development for Muscle Spasm, H1 2015 7
Number of Products under Development for Muscle Spasm - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Muscle Spasm - Pipeline by Eisai Co., Ltd., H1 2015 14
Muscle Spasm - Pipeline by Omeros Corporation, H1 2015 15
Muscle Spasm - Pipeline by Revance Therapeutics, Inc., H1 2015 16
Muscle Spasm - Pipeline by Sanochemia Pharmazeutika AG, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Assessment by Combination Products, H1 2015 19
Number of Products by Stage and Target, H1 2015 21
Number of Products by Stage and Mechanism of Action, H1 2015 23
Number of Products by Stage and Route of Administration, H1 2015 25
Number of Products by Stage and Molecule Type, H1 2015 27
Muscle Spasm Therapeutics - Recent Pipeline Updates, H1 2015 36
Muscle Spasm - Dormant Projects, H1 2015 38

List of Figures

Number of Products under Development for Muscle Spasm, H1 2015 7
Number of Products under Development for Muscle Spasm - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Assessment by Monotherapy Products, H1 2015 18
Assessment by Combination Products, H1 2015 19
Number of Products by Top 10 Targets, H1 2015 20
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25
Number of Products by Top 10 Molecule Types, H1 2015 26
Number of Products by Stage and Top 10 Molecule Types, H1 2015 27

Explore more reports on Allergy therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.